SCHEMBL312302

SCHEMBL312302

CC(C)(C)OC(=O)N1CCC(Nc2ccc3[nH]nnc3c2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
NPC1 O15118 2/20 0.60
RAB9A P51151 2/20 0.60
MAPT P10636 1/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
CNR1 P21554 2/20 0.50
DDB1 Q16531 1/20 0.49
CRBN Q96SW2 1/20 0.49
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
JAK1 P23458 1/20 0.47
GPR119 Q8TDV5 2/20 0.46
NSD2 O96028 1/20 0.46
ROCK2 O75116 2/20 0.45
CYP3A4 P08684 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7483460 0.83 ALDH1A1 (0.58) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL31110492 0.82 NAMPT (0.50) ALDH1A1MAPTHTTCNR1DDB1
SCHEMBL312320 0.81 ROCK2 (0.68) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL7483469 0.79 ALDH1A1 (0.58) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL312418 0.79 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL4115820 0.78 ALDH1A1 (0.77) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL17554400 0.78 ALDH1A1 (0.77) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL10210061 0.78 ALDH1A1 (0.79) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL179133 0.78 PTPN2 (0.49) ALDH1A1NPC1RAB9APTPN2PTPN1
SCHEMBL118545 0.78 KMT2A (0.44) L3MBTL1CRBNGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093285-B2 Aminopiperidinyl derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2012-01-10 US disclosed
EP-2268631-A1 AMINOPIPERIDINYL DERIVATIVES AND USES THEREOF F. Hoffmann-La Roche AG (CH) 2011-01-05 EP disclosed
WO-2009118254-A1 AMINOPIPERIDINYL DERIVATIVES AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2009-10-01 WO disclosed
US-20090247568-A1 AMINOPIPERIDINYL DERIVATIVES AND USES THEREOF ROCHE PALO ALTO LLC 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247568-A1 AMINOPIPERIDINYL DERIVATIVES AND USES THEREOF MAOB, ADORA2B, HTR1B ALDH1A1 524/4885NPC1 2989/4885RAB9A 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.